Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/27/2012 | CA2839887A1 Recombinant yeast expressing agt1 |
12/27/2012 | CA2839807A1 Combination therapy |
12/27/2012 | CA2839777A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease |
12/27/2012 | CA2839711A1 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes |
12/27/2012 | CA2839705A1 Multivariate diagnostic assays and methods for using same |
12/27/2012 | CA2839573A1 Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof |
12/27/2012 | CA2839563A1 Anti-alpha synuclein binding molecules |
12/27/2012 | CA2839371A1 P0 gene silencing constructs and use |
12/27/2012 | CA2839074A1 Method of metabolic evolution |
12/27/2012 | CA2838621A1 Plants having enhanced yield-related traits and a method for making the same |
12/27/2012 | CA2837658A1 Pcsk9-binding polypeptides and methods of use |
12/26/2012 | EP2537941A1 Methods and nucleotide fragments of predicting the ability of tumor invasion and metastasis in vitro |
12/26/2012 | EP2537940A2 Plants having increased yield-related traits and a method for making the same |
12/26/2012 | EP2537939A1 Tobacco plants having reduced nicotine demethylase activity |
12/26/2012 | EP2537938A2 Physcomitrella patents genes which improve stress tolerance |
12/26/2012 | EP2537937A2 Genes and uses for plant enhancement |
12/26/2012 | EP2537936A1 P0 gene silencing constructs and use |
12/26/2012 | EP2537935A2 Modified microorganism for high efficient production of lactic acid |
12/26/2012 | EP2537934A2 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
12/26/2012 | EP2537933A1 An IL-15 and IL-15Ralpha sushi domain based immunocytokines |
12/26/2012 | EP2537932A1 Compositions for and methods of identifying antigens |
12/26/2012 | EP2537931A1 Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide |
12/26/2012 | EP2537930A1 Method for producing induced pluripotent stem cells |
12/26/2012 | EP2537929A1 Plant component regulation factor, and use thereof |
12/26/2012 | EP2537928A1 Novel promoter for use in transformation of algae |
12/26/2012 | EP2537927A1 Polynucleotide encoding acyl-coa synthetase homolog and method for using the same |
12/26/2012 | EP2537926A1 Valencene synthase |
12/26/2012 | EP2537925A1 Novel restriction endonucleases, DNA encoding these endonucleases, and methods for identifying new endonucleases with the same or varied specificity |
12/26/2012 | EP2537924A2 MEK ligands and polynucleotides encoding mek ligands |
12/26/2012 | EP2537825A1 Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane |
12/26/2012 | EP2537416A1 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes |
12/26/2012 | EP2536855A1 Isolation of biomolecules from biological samples |
12/26/2012 | EP2536854A2 Personalized tumor biomarkers |
12/26/2012 | EP2536853A2 Assay for detecting closely- related serotypes of human papillomavirus (hpv) |
12/26/2012 | EP2536838A2 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response |
12/26/2012 | EP2536837A2 Nucleic acid extraction from complex matrices |
12/26/2012 | EP2536836A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
12/26/2012 | EP2536835A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
12/26/2012 | EP2536834A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
12/26/2012 | EP2536833A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
12/26/2012 | EP2536832A1 Amylase from nesterenkonia and methods of use, thereof |
12/26/2012 | EP2536831A2 Improved meganuclease recombination system |
12/26/2012 | EP2536829A1 Method for the production of ad26 adenoviral vectors |
12/26/2012 | EP2536821A2 Improving activity of fe-s cluster requiring proteins |
12/26/2012 | EP2536761A2 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof |
12/26/2012 | EP2536759A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
12/26/2012 | EP2536757A1 Fibronectin based scaffold domain proteins that bind il-23 |
12/26/2012 | EP2536750A1 Rage fusion protein compositions and methods of use |
12/26/2012 | EP2536748A1 Neuregulin antagonists and use thereof in treating cancer |
12/26/2012 | EP2536741A2 Gene fusion targeted therapy |
12/26/2012 | EP2536738A1 Methods and compositions useful in treatment of diseases or conditions related to repeat expansion |
12/26/2012 | EP2536433A2 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases |
12/26/2012 | EP2536428A1 Universal virus-like particle (vlp) influenza vaccines |
12/26/2012 | EP2536423A2 SUPPRESSORS OF RNA SILENCING AS MODULATORS OF miRNA LEVELS |
12/26/2012 | EP2536406A2 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
12/26/2012 | EP2536267A2 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE |
12/26/2012 | EP2536266A2 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
12/26/2012 | EP2468860A9 Transformant and process for production thereof, and process for production of lactic acid |
12/26/2012 | EP2453017A9 Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases |
12/26/2012 | EP2298898B1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
12/26/2012 | EP2292754B1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
12/26/2012 | EP2287302B1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
12/26/2012 | CN1965086B Polyvalent viral vectors and a system for production thereof |
12/26/2012 | CN1794908B Method for cloning in the rat by nuclear transfer |
12/26/2012 | CN102844447A Food-poisoning bacteria detection carrier, and method for detecting food-poisoning bacteria |
12/26/2012 | CN102844446A Method for distinguishing target base sequence |
12/26/2012 | CN102844444A Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
12/26/2012 | CN102844440A Method for producing 1,5-pentanediamine |
12/26/2012 | CN102844439A Recombinant microorganism and method for producing aliphatic polyester by using the same |
12/26/2012 | CN102844438A Plants having enhanced yield-related traits and method for making the same |
12/26/2012 | CN102844437A Production of proteins and polypeptides |
12/26/2012 | CN102844436A Aptamer for ngf and use thereof |
12/26/2012 | CN102844435A Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
12/26/2012 | CN102844434A Modulation of cetp expression |
12/26/2012 | CN102844433A Primer set for pcr, reaction liquid for pcr, and method for detecting food poisoning bacteria |
12/26/2012 | CN102844432A Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand |
12/26/2012 | CN102844431A Diacylglycerole acyltranferase gene, and use thereof |
12/26/2012 | CN102844329A Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same |
12/26/2012 | CN102843904A Excision of transgenes in genetically modified organisms |
12/26/2012 | CN102841200A Use of pIgR as molecular marker of early recurrence and/or metastasis of tumor and intervening target spot of anti-tumor metastasizing medicine |
12/26/2012 | CN102839226A Amplification primer of competitive template for detecting poultry tembusu virus through QC-PCR (quantitative competitive-polymerase chain reaction), preparation method and poultry tembusu virus detection kit |
12/26/2012 | CN102839221A Primer pair, kit and detection method for detecting humpback grouper |
12/26/2012 | CN102839220A Molecular marker for identifying mitochondrion gene related to CMS (cytoplasmic male sterility) in green Chinese onion |
12/26/2012 | CN102839219A Molecule identifying method for vibrio cholerae epidemic strain, ISSR-PCR (Inter Simple Sequence Repeat-Polymerase Chain Reaction) primer and kit thereof |
12/26/2012 | CN102839210A Thiobacillus ferrooxidans detection probe composition and related detection method |
12/26/2012 | CN102839196A Transformation system containing cell-penetrating peptide and improving maize transgenic efficiency and method |
12/26/2012 | CN102839195A Method for expression of PCV 2 Cap protein by pFast Bac Dual baculovirus |
12/26/2012 | CN102839194A Recombinant adeno-associated virus vector, and preparation method and application thereof |
12/26/2012 | CN102839193A Detection method for compound specificity through G protein-coupled receptor (GPCR) |
12/26/2012 | CN102839192A miRNA (micro Ribonucleic Acid) absorption carrier, preparation method and uses thereof |
12/26/2012 | CN102839191A Increased seed size and seed number through transgenic over expression of a growth and/or development related gene during early embryo development |
12/26/2012 | CN102839190A Method for shortening plant cell suspension culture period |
12/26/2012 | CN102839189A Method for high efficiency expression of PCV 2 Cap protein by pCold-sumo expression vector |
12/26/2012 | CN102839188A Homonymous tandem co-expression bi-color fluorescent protein report gene vector |
12/26/2012 | CN102839187A miR-29 absorption sequence, absorption carrier and uses thereof |
12/26/2012 | CN102839186A Preparation and application of recombinant Mycobacterium smegmatis expressing NY-ESO-1 |
12/26/2012 | CN102839185A Construction method and application technology of rolGLP-HV engineering bacterium |
12/26/2012 | CN102839184A Recombinant ribose-5-phosphate isomerase and application thereof |
12/26/2012 | CN102839183A Preparation method and application of recombinant enterovirus 71 type virus-like particle |
12/26/2012 | CN102839182A Method for preparing recombinant human nerve growth factor by using Escherichia coli expression system |